RxDoctor Payments Data

Tim Greten

Hematology & Oncology · Bethesda, MDNPI 1518231000

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $9,257 of the $10,059 with a category attached, or 92.0%. Merck accounts for 72.1% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $7,360 and has fallen 97.7% since, to $168 in 2025.

$10,059in general payments, 2019–2025

Across 16 payments — averaging $628.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$7K
  • Astrazeneca UK Limited$2K
  • Astrazeneca AB$188
  • Exelixis Inc.$168
  • AstraZeneca$135
  • Genentech USA, Inc.$111
$4,230,313in research payments, 2019–2025

Across 12 payments — averaging $352,526 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$2.6M
  • Merck$960K
  • Astrazeneca UK Limited$319K
  • Novartis$312K
  • E.r. Squibb & Sons, L.L.C.$76K

What the payments were for

  • Travel & lodging$9,25792%
  • Food & beverage$8028%

General payments by program year

20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,059 in reported general payments places this provider in the 70th percentile of 242 hematology & oncology providers in Maryland.

See all hematology & oncology providers in Maryland

Other hematology & oncology in Bethesda

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →